Science 2.0: A novel personalized medicine initiative
We recognize that the results of sequencing alone are often not actionable for patients. Science 2.0 takes it a step further. Each patient enrolled in Science 2.0 receives genome sequencing, a personal team of scientific experts dedicated to analyzing their results, and a pro-bono consulting team of world-leading physicians and researchers in rare diseases. Our multi-faceted, patient centered program ensures that every patient with a rare and undiagnosed disease benefits from the latest research. There are six main components: